Alberto Mantovani | |
|---|---|
 | |
| Born | October 29, 1948 Milan, Italy |
| Alma mater | University of Milan |
| Known for | |
| Awards | Robert Koch Prize, see text for others |
| Scientific career | |
| Fields | Immunology |
| Institutions | University of Milan Humanitas University University of Brescia Mario Negri Institute for Pharmacological Research |
| Website | Page at Humanitas |
Alberto Mantovani Commendatore OMRI (born 29 October 1948) is an Italian physician and immunologist. He is Scientific Director of Istituto Clinico Humanitas (Humanitas Clinical and Research Center), President and Founder of the Fondazione Humanitas per la Ricerca, and Professor of Pathology at the State University of Milan.[1] He is known for his works in the roles of the immune system in the development of cancer. His research on tumor-associated macrophages (TAM, an acronym he coined) established inflammation as one of the causes of cancer. He was the first to identify monocyte chemotactic protein - 1 / CCL2 in 1983, and PTX3 in 1997. His works revealed the existence of decoy receptors in cell-signalling. He has been the most cited scientist in Italy, and one of the ten most cited immunologists worldwide.[2]
- ^ "Biography—Alberto Mantovani, MD". Cancer and Metastasis Reviews. 29 (2): 239. 2010. doi:10.1007/s10555-010-9219-2.
- ^ "Mantovani Alberto, MD". www.humanitas-research.org. Humanitas Clinical and Research Center, Italy. Archived from the original on 25 June 2016. Retrieved 27 July 2016.